NOVN Novan Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NOVN

Price (delayed)

$0.0941

Market cap

$2.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$1.22M

Novan, Inc. is a clinical development-stage biotechnology company focused on leveraging its proprietary nitric oxide (NO) based technology platform, NITRICIL™ to generate macromolecular New Chemical Entities (NCEs) to treat multiple ...

Highlights
NOVN's debt is down by 43% year-on-year and by 17% since the previous quarter
The EPS rose by 30% year-on-year and by 7% since the previous quarter
The net income has grown by 6% YoY but it has contracted by 2.4% from the previous quarter
NOVN's equity has dropped by 161% since the previous quarter and by 148% year-on-year
Novan's quick ratio has decreased by 44% YoY and by 18% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.novan.com
Peers: OCUP

Key stats

What are the main financial stats of NOVN
Market
Shares outstanding
28.02M
Market cap
$2.64M
Enterprise value
$1.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.05
Earnings
Revenue
$24.92M
EBIT
-$30.4M
EBITDA
-$26.95M
Free cash flow
-$39.27M
Per share
EPS
-$1.32
Free cash flow per share
-$1.5
Book value per share
-$0.1
Revenue per share
$0.95
TBVPS
$1.87
Balance sheet
Total assets
$79.79M
Total liabilities
$82.62M
Debt
$11.77M
Equity
-$2.83M
Working capital
-$11.22M
Liquidity
Debt to equity
-4.16
Current ratio
0.74
Quick ratio
0.62
Net debt/EBITDA
0.05
Margins
EBITDA margin
-108.1%
Gross margin
66.1%
Net margin
-128.6%
Operating margin
-143%
Efficiency
Return on assets
-34.9%
Return on equity
-616.8%
Return on invested capital
-319.5%
Return on capital employed
-84.7%
Return on sales
-122%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NOVN stock price

How has the Novan stock price performed over time
Intraday
-24.84%
1 week
-44.12%
1 month
-77.6%
1 year
-96.63%
YTD
-93.55%
QTD
-78.12%

Financial performance

How have Novan's revenue and profit performed over time
Revenue
$24.92M
Gross profit
$16.46M
Operating income
-$35.63M
Net income
-$32.05M
Gross margin
66.1%
Net margin
-128.6%
NOVN's net margin has surged by 85% year-on-year and by 2.7% since the previous quarter
Novan's operating margin has surged by 83% YoY and by 4.3% QoQ
Novan's gross margin has decreased by 30% YoY and by 3.9% from the previous quarter
The net income has grown by 6% YoY but it has contracted by 2.4% from the previous quarter

Growth

What is Novan's growth rate over time

Valuation

What is Novan stock price valuation
P/E
N/A
P/B
N/A
P/S
0.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.05
The EPS rose by 30% year-on-year and by 7% since the previous quarter
NOVN's equity has dropped by 161% since the previous quarter and by 148% year-on-year
The P/S is 99% lower than the 5-year quarterly average of 15.2 and 96% lower than the last 4 quarters average of 2.7
NOVN's revenue is up by 5% QoQ

Efficiency

How efficient is Novan business performance
The return on sales has surged by 85% year-on-year and by 3.3% since the previous quarter
Novan's ROE has decreased by 45% from the previous quarter
NOVN's return on invested capital is down by 27% since the previous quarter but it is up by 17% year-on-year
Novan's return on assets has increased by 14% YoY but it has decreased by 12% QoQ

Dividends

What is NOVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NOVN.

Financial health

How did Novan financials performed over time
The total assets is 3.4% lower than the total liabilities
Novan's quick ratio has decreased by 44% YoY and by 18% from the previous quarter
The current ratio has declined by 41% year-on-year and by 19% since the previous quarter
NOVN's equity has dropped by 161% since the previous quarter and by 148% year-on-year
NOVN's debt is down by 43% year-on-year and by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.